NHE3 Inhibitors for IBS-C: A Georgia Gastroenterologist’s Perspective
Physician’s Weekly recently spoke with Satish SC Rao, MD, PhD, FRCP, FACG, AGAF about NHE3 inhibitors and their unique method of action (MOA) in treating patients with IBS-C.
Read More